Hayley Evans/LinkedIn
Jul 22, 2026, 08:58
Hayley Evans: Exploring TXA in Surgery and Its Role in Reducing Blood Loss
Hayley Evans, Deputy Director at the NIHR Blood and Transplant Research Unit in Data Driven Transfusion Practice, shared a post on LinkedIn:
“Many of you will be aware of the growing evidence around tranexamic acid (TXA) in surgery and its role in reducing blood loss.
Our new Medscape piece ‘Implementing Updated NICE Guidance on Tranexamic Acid in Surgery:
Moving from Evidence to Routine Practice’ looks at practical steps to help increase appropriate TXA use and support more consistent routine practice.”
Stay updated with Hemostasis Today.
-
Sep 18, 2026, 17:48Ronak H. Mistry: Updated ASH Guidelines Bring New Focus to Iron Deficiency
-
Sep 18, 2026, 17:32Hassan Kawtharany: New Ferritin Cutoffs for the Diagnosis of Iron Deficiency With or Without Anemia
-
Sep 18, 2026, 17:20Abhishek G P: GAVE as an Important Cause of Chronic Gastrointestinal Blood Loss
-
Sep 18, 2026, 17:08Irem Karaman Sebin: ASH 2026 Changes a Key Concept in Iron Deficiency
-
Sep 18, 2026, 16:51Adarsh Krishnan Sundara Rajan: Is VTE the Most Underdiagnosed Critical Threat in Modern Healthcare?
-
Sep 18, 2026, 16:19CRISPR and Hemophilia: The Next Frontier of In Vivo Gene Editing
-
Sep 18, 2026, 16:13Christian Irsara: PF4 Immunothrombosis Following Natural Adenovirus Infection
-
Sep 18, 2026, 16:10Leo Nicolai։ The Spleen Emerges as a Key Regulator of Thromboinflammation
-
Sep 18, 2026, 16:05Targeting Factor XI to Reduce Thrombosis Without Compromising Hemostasis – ISTH